Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $26.6100 (3.02%) ($25.9300 - $26.8000) on Mon. Oct. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.08% (three month average) | RSI | 41 | Latest Price | $26.6100(3.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.6% a day on average for past five trading days. | Weekly Trend | HALO declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.04% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-5%) DRIV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.04% (StdDev 2.08%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $26.82 | 5 Day Moving Average | $26.36(0.95%) | 10 Day Moving Average | $26.2(1.56%) | 20 Day Moving Average | $26.82(-0.78%) | To recent high | -10.1% | To recent low | 3.4% | Market Cap | $3.637b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |